Physician

Sushil Kumar Singhi, M.D.

According to 2025 Medicare claims, Sushil Singhi, M.D. (NPI: 1457304628) practices cardiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is CAROLINA CARDIOLOGY ASSOCIATES LLC (NPI: 1134166507; TIN: 57-0989765) and primary practice location at 29732-3542.

Singhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,122 traditional Medicare patients, billed 11,771 HCPCS/CPT codes, and received $671,473 in Medicare payments. The top billing code was 95800 (Sleep study including heart rate, breathing, and sleep time). Part D data shows 3,792 prescription claims across 812 beneficiaries totaling $526,194 in drug costs, led by Eliquis (Apixaban). DME data shows 3,279 claims. Open Payments data shows 23 records totaling $6,170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $670,686 and ending at $671,473. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and rose steadily, from $64,425 to $127,604.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$423K$847K2015 Medicare payment: $670,686 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $699,012 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $846,653 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $826,140 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $635,057 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $505,128 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $436,811 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $439,485 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $591,681 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $671,473 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,01022,875$670,686
20162,05020,329$699,012
20172,38920,606$846,653
20182,23521,181$826,140
20191,87916,908$635,057
20201,63514,272$505,128
20211,35412,953$436,811
20221,09914,557$439,485
20231,24415,668$591,681
20241,12211,771$671,473

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$315K$631K2015 Drug cost: $384,257 (USD; Tot_Drug_Cst)2016 Drug cost: $564,899 (USD; Tot_Drug_Cst)2017 Drug cost: $621,078 (USD; Tot_Drug_Cst)2018 Drug cost: $484,556 (USD; Tot_Drug_Cst)2019 Drug cost: $547,105 (USD; Tot_Drug_Cst)2020 Drug cost: $509,154 (USD; Tot_Drug_Cst)2021 Drug cost: $563,494 (USD; Tot_Drug_Cst)2022 Drug cost: $509,440 (USD; Tot_Drug_Cst)2023 Drug cost: $630,820 (USD; Tot_Drug_Cst)2024 Drug cost: $526,194 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157975,700$384,257
20168316,428$564,899
20178206,396$621,078
20188536,044$484,556
20197944,769$547,105
20207784,614$509,154
20218394,299$563,494
20228283,970$509,440
20239374,282$630,820
20248123,792$526,194

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$66K$131K2015 Medicare payment: $64,061 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $78,381 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $77,474 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $94,904 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $84,832 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $105,564 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $131,169 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $92,383 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $114,345 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $123,056 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20156541,594$64,061
20168972,108$78,381
20171,1632,613$77,474
20181,1703,041$94,904
20191,1882,823$84,832
20201,5273,517$105,564
20211,5474,305$131,169
20221,1952,696$92,383
20231,2733,265$114,345
20241,2653,279$123,056

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95800Sleep study including heart rate, breathing, and sleep time117117$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more448961$91
94660Therapy procedure using a positive pressure ventilator155251$45
99426Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month120219$44
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's328521$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban25415,135$289,704
XareltoRivaroxaban412,445$46,671
EntrestoSacubitril/Valsartan231,770$40,011
FarxigaDapagliflozin Propanediol271,710$32,660
BrilintaTicagrelor381,746$25,429

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A7031Face mask interface, replacement for full face mask, eachN76197$18,428
A7030Full face mask used with positive airway pressure device, eachN86194$16,990
A7032Cushion for use on nasal mask interface, replacement only, eachN62158$16,402
E0601Continuous positive airway pressure (cpap) deviceY94463$14,978
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapN110265$13,847

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.19$970Inspire Medical Systems, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$5,200Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sushil Kumar Singhi, M.D.?

Tedicare shows public-source Medicare data for Sushil Kumar Singhi, M.D. (NPI 1457304628), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sushil Kumar Singhi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sushil Kumar Singhi, M.D.?

Sushil Kumar Singhi, M.D. is linked to CAROLINA CARDIOLOGY ASSOCIATES LLC (billing NPI 1134166507) in the available physician profile data.

Does Sushil Kumar Singhi, M.D. have Open Payments data?

Sushil Kumar Singhi, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.